Comparison between the Effects of Urapidil and Methyldopa on Left Ventricular Hypertrophy and Haemodynamics in Humans
- 1 January 1988
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 35 (6) , 90-97
- https://doi.org/10.2165/00003495-198800356-00013
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Regression of cardiovascular structural changes by antihypertensive treatment. Functional consequences and time course of reversal as judged from clinical studies.Hypertension, 1984
- Reversal of cardiac hypertrophy in humans.Hypertension, 1984
- Left ventricular mass reduction during salt depletion in arterial hypertension.Hypertension, 1984
- Reliable estimation of peak left ventricular systolic pressure by M-mode echographic-determined end-diastolic relative wall thickness: Identification of severe valvular aortic stenosis in adult patientsAmerican Heart Journal, 1982
- Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings.Circulation, 1981
- Effect of converting enzyme inhibitor (SQ14,225) on myocardial hypertrophy in spontaneously hypertensive rats.Hypertension, 1980
- Serial noninvasive assessment of left ventricular hypertrophy and function after surgical correction of aortic regurgitationThe American Journal of Cardiology, 1979
- Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy?The American Journal of Cardiology, 1979
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978
- Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.Circulation, 1977